Clinical Trials · NCT00066703
Triptorelin With Either Exemestane or Tamoxifen in Treating Premenopausal Women With Hormone-Responsive Breast Cancer
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- ETOP IBCSG Partners Foundation
- Enrollment
- 2,672
- Start date
- Nov 2003
- Locations
- 228 sites, 17 countries
- Primary endpoint
- Disease-free Survival